OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
40
Results
Show all
Save search
Copy query
Show results for
Unknown
(40)
Release Date
2025
(9)
2021
(8)
2024
(7)
2022
(6)
2023
(5)
2020
(2)
2016
(1)
2015
(1)
2013
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
State-selective small molecule degraders that preferentially remove aggregates and oligomers.
Not available
S-EPMC12647892
|
biostudies-literature
Cite
Reference Library for Suspect Non-targeted Screening of Environmental Toxicants Using Ion Mobility Spectrometry-Mass Spectrometry.
Not available
S-EPMC11888245
|
biostudies-literature
Cite
Reference library for suspect screening of environmental toxicants using ion mobility spectrometry-mass spectrometry.
Not available
S-EPMC12317010
|
biostudies-literature
Cite
Multidimensional library for the improved identification of per- and polyfluoroalkyl substances (PFAS).
Not available
S-EPMC11763048
|
biostudies-literature
Cite
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Not available
S-EPMC7614824
|
biostudies-literature
Cite
Effectiveness of Iodophor vs Chlorhexidine Solutions for Surgical Site Infections and Unplanned Reoperations for Patients Who Underwent Fracture Repair: The PREP-IT Master Protocol.
Not available
S-EPMC7139274
|
biostudies-literature
Cite
Pragmatic randomized trial evaluating pre-operative aqueous antiseptic skin solution in open fractures (Aqueous-PREP): the feasibility of a cluster randomized crossover study.
Not available
S-EPMC7919062
|
biostudies-literature
Cite
Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
Not available
S-EPMC4059359
|
biostudies-literature
Cite
Autoimmune disease and COVID-19: a multicentre observational study in the United Kingdom.
Not available
S-EPMC8992350
|
biostudies-literature
Cite
Association of COVID-19 With Achieving Time-to-Surgery Benchmarks in Patients With Musculoskeletal Trauma.
Not available
S-EPMC8727030
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets